About BioPhero
BioPhero is a company based in Copenhagen (Denmark) founded in 2018 by Carina Holkenbrink.. BioPhero has raised $21.75 million across 6 funding rounds from investors including European Union, DCVC and Novo Holdings. The company has 14 employees as of June 30, 2020. BioPhero operates in a competitive market with competitors including Provivi, Oxitec, PheroSyn, Barrix Agro Sciences and Pheronym, among others.
- Headquarter Copenhagen, Denmark
- Employees 14 as on 30 Jun, 2020
- Founders Carina Holkenbrink
- Stage Minicorn
-
Sectors
Chemicals & MaterialsAgriculture
-
Email
***********
-
Phone
*********
-
Website
*********
-
Social
*********
- Legal Name Biophero Aps
-
Annual Revenue
-
Net Profit
$-1.39 M (USD)-92as on Dec 31, 2020
-
EBITDA
-
Total Equity Funding
$21.75 M (USD)
in 6 rounds
-
Latest Funding Round
$17 M (USD), Series A
Feb 12, 2021
-
Investors
European Union
& 5 more
-
Employee Count
14
as on Jun 30, 2020
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Unlock access to complete
Unlock access to complete
Software Development Team
73 people
Leadership Team
53 people
Finance and Accounting
43 people
Sales and Marketing
34 people
Human Resources and Administration
30 people
Global Team
15 people
Senior Team
15 people
Product Management Team
14 people
Unlock access to complete
Funding Insights of BioPhero
BioPhero has successfully raised a total of $21.75M across 6 strategic funding rounds. The most recent funding activity was a Series A round of $17 million completed in February 2021. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 6
- Last Round Series A — $17.0M
-
First Round
First Round
(01 Jan 2018)
- Investors Count 6
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Feb, 2021 | Amount | Series A - BioPhero | Valuation | DCVC | |
| Dec, 2019 | Amount | Seed - BioPhero | Valuation |
investors |
|
| Apr, 2019 | Amount | Grant - BioPhero | Valuation |
investors |
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in BioPhero
BioPhero has secured backing from 6 investors, including venture fund and institutional investors. Prominent investors backing the company include European Union, DCVC and Novo Holdings. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Venture capital firm focused on multiple sectors
|
Founded Year | Domain | Location | |
|
Private equity and venture capital fund focused on the healthcare sector
|
Founded Year | Domain | Location | |
|
-
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by BioPhero
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - BioPhero
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Biophero Comparisons
Competitors of BioPhero
BioPhero operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Provivi, Oxitec, PheroSyn, Barrix Agro Sciences and Pheronym, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Developer of biocatalyst and fermentation technology for pest control
|
|
| domain | founded_year | HQ Location |
Genetically modified insects are developed to suppress pest populations.
|
|
| domain | founded_year | HQ Location |
Provider of pheromone-based integrated pest management solution
|
|
| domain | founded_year | HQ Location |
Manufacturer of pheromone traps and plant management solutions
|
|
| domain | founded_year | HQ Location |
Developer of nematode pheromone-based crop protection products
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Latest news on Biophero
Frequently Asked Questions about BioPhero
When was BioPhero founded?
BioPhero was founded in 2018.
Where is BioPhero located?
BioPhero is headquartered in Copenhagen, Denmark.
Who is the current CEO of BioPhero?
Kristian Ebbensgaard is the current CEO of BioPhero.
Is BioPhero a funded company?
BioPhero is a funded company, having raised a total of $21.75M across 6 funding rounds to date. The company's 1st funding round was a Grant of $245.75K, raised on Jan 01, 2018.
How many employees does BioPhero have?
As of Jun 30, 2020, the latest employee count at BioPhero is 14.
What does BioPhero do?
BioPhero was established in 2018 in Copenhagen, Denmark. Insect pheromones are manufactured via a fermentation process involving yeasts, targeting pest control in agriculture. Solutions are provided for specialty crops including apples and grapes. Operations focus on the biotechnology sector, with headquarters located in Lyngby, supporting sustainable pest management practices across Europe.
Who are the top competitors of BioPhero?
Who are BioPhero's investors?
BioPhero has 6 investors. Key investors include European Union, DCVC, Novo Holdings, FMC Ventures, and Syngenta Group.
What is BioPhero's valuation?
The valuation of BioPhero is $21.4M as of Feb 2021.
Book a demo & talk to our team
Share a few details and we’ll reach out to schedule a session.